Get daily under-the-radar research with StreetInsider.com’s Stealth Growth Insider Get your 2-Wk Free Trial here.
Endo International plc (NASDAQ: ENDP) announced today that as part of its comprehensive organizational review, it has initiated a restructuring program. These restructuring actions primarily relate to the Company’s Corporate functions and Branded pharmaceutical R&D functions in Malvern, PA and Chestnut Ridge, NY. The restructuring program will better align these parts of our organization in size and scope with the Company’s recently restructured Generics and U.S Branded Pharmaceutical business units. In addition to realizing greater efficiencies, these actions are expected to provide corresponding cost savings. End…
Read the full article at: http://www.streetinsider.com/Corporate News/Endo (ENDP) Announces Restructuring; to Reduce Work Force by 90 Positions/12460929.html